Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01840579
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Who this might be right for
Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer
Merck Sharp & Dohme LLC 57
Testing effectiveness (Phase 2)Study completedNCT00403403
What this trial is testing

Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)

Who this might be right for
Small Cell Lung Cancer
Genentech, Inc. 102
Not applicableUnknownNCT04306094
What this trial is testing

Factors Determining the Prognosis in NSCLC Stage IV

Who this might be right for
NSCLC Stage IV
Instituto do Cancer do Estado de São Paulo 217
Not applicableStudy completedNCT00263731
What this trial is testing

Metabolomic Analysis of Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell Lung
University of Louisville 249
Testing effectiveness (Phase 2)Study completedNCT04681131
What this trial is testing

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
BioAtla, Inc. 85
Testing effectiveness (Phase 2)Ended earlyNCT01222572
What this trial is testing

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerLung CancerNSCLC
Dana-Farber Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT01635270
What this trial is testing

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more
Centre Leon Berard 54
Testing effectiveness (Phase 2)Study completedNCT00282022
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals 87
Large-scale testing (Phase 3)Study completedNCT00632853
What this trial is testing

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 731
Testing effectiveness (Phase 2)Ended earlyNCT02161419
What this trial is testing

RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 142
Testing effectiveness (Phase 2)Looking for participantsNCT07603856
What this trial is testing

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMetastatic Lung Cancer
University of Chicago 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Looking for participantsNCT03808337
What this trial is testing

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Who this might be right for
Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more
Memorial Sloan Kettering Cancer Center 145
Large-scale testing (Phase 3)Study completedNCT02395172
What this trial is testing

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
EMD Serono Research & Development Institute, Inc. 792
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT07703228
What this trial is testing

Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVSecond-line Therapy+1 more
Nanfang Hospital, Southern Medical University 38
Not applicableNot Yet RecruitingNCT07670442
What this trial is testing

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00984542
What this trial is testing

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00088556
What this trial is testing

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Telik 100
Next Page